Kanlayanee Sawanyawisuth

7PUBLICATIONS
12CO-AUTHORS
Haematological tumoursMolecular targetsCancer cell biologySurveying (incl. hydrographic surveying)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 06, 2026
HMGA1 is associated with unfavorable outcome and accelerates the aggressiveness of cholangiocarcinoma.

|Aug 11, 2025
High cyclic GMP-AMP synthase and stimulator of interferon genes in cholangiocarcinoma suggest their potential as targets for treatment.

Han Ni Zin Myint, Paksiree Saranaruk, Natnicha Paungpan

|Jul 27, 2024
Overexpression of BubR1 Mitotic Checkpoint Protein Predicts Short Survival and Influences the Progression of Cholangiocarcinoma.

Nongnapas Pokaew, Piya Prajumwongs, Kulthida Vaeteewoottacharn

|May 31, 2022
HMGN3 represses transcription of epithelial regulators to promote migration of cholangiocarcinoma in a SNAI2-dependent manner.

Supannika Sorin, Sho Kubota, Sofiane Hamidi

|Feb 28, 2022
Annexin A1 Is a Potential Prognostic Marker for, and Enhances the Metastasis of, Cholangiocarcinoma.

Kwuntida U Kotepui, Sumalee Obchoei, Kulthida Vaeteewoottacharn

|Mar 06, 2021
Epithelial-Mesenchymal Transition in Liver Fluke-Induced Cholangiocarcinoma.

Kanlayanee Sawanyawisuth, Goro Sashida, Guojun Sheng

Pageof 2

Frequent Collaborators

3 joint publications

Kulthida Vaeteewoottacharn

2 joint publications

Goro Sashida

1 joint publications

Worachart Lert-Itthiporn

1 joint publications

Sho Kubota